Filing Details

Accession Number:
0001179110-12-004228
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-05 16:12:14
Reporting Period:
2012-03-01
Filing Date:
2012-03-05
Accepted Time:
2012-03-05 16:12:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157601 Synta Pharmaceuticals Corp SNTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325715 S Keith Ehrlich C/O Synta Pharmaceuticals Corp.
45 Hartwell Avenue
Lexington MA 02421
Vp, Fin. And Admin., Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-03-01 4,397 $4.70 17,573 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2011, and were made in part to fund certain out-of-pocket tax withholding liabilities associated with the vesting of restricted stock granted on March 1, 2011.
  2. The shares were sold in multiple transactions at prices ranging from $4.63 to $4.80 per share. The price reported above is the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.